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ABSTRACT
Objective: The main goals of the study were to isolate oligosaccharide as a secondary metabolite from indigenous fruit, Averrhoa carambola L. (star 
fruit), and analyze its anti-Helicobacter pylori and immunostimulatory potential.
Methods: The oligosaccharide (S3W) isolated using adsorption chromatography was partially characterized using tandem mass spectrometry in 
atmospheric pressure chemical ionization/electron spray ionization (APCI/ESI) positive and negative mode and nuclear magnetic resonance. The 
use of microtiter well method determined anti-H. pylori activity in the form of percentage inhibition of microbial growth, while the determination 
of the immunostimulatory potential of S3W implemented a protection of DNA, buccal cells, and macrophages against damage by oxidant and 
N-nitroso-N- methylurea (MNU) and percentage splenocyte proliferative potential.
Results: S3W was a (1→2) β-heptaglucosaccharide with (4→6) α-branching at every second residue. APCI/ESI-positive mode showed B and A 
fragmentation patterns, while the negative mode showed abundance of A and C fragments. Anomeric hydrogen displayed integration values at 4.8 
and 4.2 ppm indicating the presence of α-glucopyranose and β-glucopyranose. The compound protected DNA from oxidant-induced fragmentation. 
It expressed anti-H. pyloric activity with an IC50 value of 10.71 µg/ml. At 20 µg/ml, S3W protected buccal cells and macrophages significantly from 
damage due to oxidants and MNU carcinogens, while >50% splenocyte proliferation was induced as compared to that of an untreated control group.
Conclusion: Our studies constitute the first report on the significant immunostimulatory activity of the oligosaccharide isolated from star fruit. The 
study, thus, supports its application as a therapeutic potential in curbing gastric diseases caused by H. pylori.
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INTRODUCTION
The Gram-negative bacterium, Helicobacter pylori, can colonize in 
human gastric mucosa of an infected individual without causing clinical 
illness [1,2]. The development of gastric adenocarcinoma, gastric 
lymphoma, and mucosa-associated lymphoid tissue lymphoma in 
association with long-term H. pylori infection has classified H. pylori 
as a carcinogen [3-6]. It induces inflammation, reactive oxygen species 
(ROS) accumulation, infiltration and activation of immune cells, and 
oxidative damage to DNA in the gastric mucosa by protecting itself 
from death through instigating apoptosis to macrophages [2,7-9]. Its 
clinical manifestation is associated with factors such as host genetic 
factors, virulence factor of the bacteria, and its environment [10]. 
Hence, H. pylori on prolonged existence survives by manipulating 
the host immune response and creates a prosurvival and tolerant 
environment for itself which is harmful for the host. Treatment of 
H. pylori infection uses a combination of minimum two antibiotics and 
gastric acid inhibitors which often causes side effects such as nausea, 
antibiotic resistance, and recurrence [5]. The search for a safe and 
effective non- antibiotic agent has rekindled the interest in alternative 
medicine in the form of natural drugs. Herbal formulation or isolation of 
bioactive compounds is widely investigated, particularly in indigenous 
fruits known for their folkloric medicinal value [11]. Development of 
carbohydrates and carbohydrate-based molecules in drug discovery 
in the form of glycomics has attained increased recognition [12]. 
Recent advances in oligosaccharide research have established its 
application in therapy for areas such as inflammation, immunity, 
oncology, neurodegenerative diseases, and infection [13,14]. Synthetic 
oligosaccharides tested for its antibiotic potential against H. pylori were 
studied [15], while carbohydrates present in porcine milk were found to 
mediate prevention of H. pylori colonization [16]. However, substantial 
reports on the effect of oligosaccharides from plants against the 
bacteria are limited despite its antimicrobial potential. The challenge 
could be due to the natural oligosaccharides possessing diverse 
structural and size heterogeneity, challenging the ability to determine 
its detailed structure. Using biochemical tools such as chromatographic 
separations for isolation and characterization using spectral analysis 
such as mass spectra (MS) and nuclear magnetic resonance (NMR), 
drug discoveries have obtained success rates. Our study, thus, identifies 
the oligosaccharides isolated from star fruit and explores its potential 
as an anti-H. pyloric agent through immunostimulatory effects for the 
first time since the fruit is known to alleviate problems of the gut.
Starfruit (Averrhoa carambola L.) is a tree fruit with a distinctive star 
shape in cross-section. The edible fruit of the Oxalidaceae family is 
available locally in various products such as pickles, jam, or jelly. The 
powdered seed concoction of the fruit is traditionally used for its 
medicinal properties to treat hemorrhoids, fever, eczema, diarrhea, and 
asthma [17,18]. Extensive reports on the strong free radical scavenging 
potential of juice and residue of star fruit cultivated in Singapore 
and Indonesia have attributed its capacity to the rich procyanidin 
polymers and β-carotene [19]. Antioxidant and immunomodulatory 
effects of star fruit leaves were evidenced through increased antibody 
titer values and hematological profile in cyclophosphamide-induced 
immunosuppressed mice [20]. Our earlier reports established the 
antioxidant potential and anticancer properties of star fruit [21,22]. 
The present investigation is, therefore, the first to report the isolation of 
an oligosaccharide from star fruit (S3W) and its anti-H. pylori potential 
through its immunostimulatory ability.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i2.28244
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METHODS
Plant material
A. carambola fruit was procured from the local market of Mysore, 
Karnataka, during July–September. A herbarium specimen was 
deposited at the Herbarium Center, DOS in Botany, Manasagangothri, 
Mysuru (VS. No. DOSBWK05).
Preparation of extract
About 500 g of fresh fruit was blended and extracted with 1000 ml of 
60% acetone/water at 30°C for 3 h under continuous agitation and 
filtered using a muslin cloth. The residue was reextracted using 500 ml 
of solvent mixture under the same conditions and the filtrates pooled. 
After concentration in a rotary evaporator (Buchi, Germany), the 
aqueous portion was dried in a hot-air oven at 50°C.
Isolation of star fruit oligosaccharide
A sequence of biphase extraction on the aqueous extract of star fruit 
included using 10% ethyl acetate in methanol, 20% ethyl acetate in 
methanol, and 30% ethyl acetate in methanol, wherein the aqueous 
phase in each period of extraction was collected and subjected to further 
biphase separation. At 40% ethyl acetate in methanol, the obtained 
monophase was dried at 40°C. 5 g of the dried extract was reconstituted 
in methanol and subjected to ethyl acetate equilibrated silica gel 
chromatography of 300 mm × 10 mm column size using silica gel 
60–120 mesh. A gradient of ethyl acetate: methanol (10:0, 8:2, 6:4, 4:6, 
2:8, and 0:10) as mobile phase resulted in six fractions (S1-S6), of which 
fraction S3 was subjected to preparative thin-layer chromatography 
using the mobile phase ethyl acetate: methanol:water (1.65:9:1.35) and 
observed under UV. The blue fluorescing spot at Rf 0.63 (Supplementary 
material 1) was extracted using methanol and dried at 40°C to give S3W. 
S3W underwent analysis by phenol- sulfuric acid method to confirm 
the presence of carbohydrates [23] and was further subjected to liquid 
chromatography -electron spray ionization (ESI)/atmospheric pressure 
chemical ionization (APCI)- MS/MS, and 1H and 13C NMR.
High-performance liquid chromatography (HPLC)-ESI-mass 
spectrometry (ESI-MS) analyses of S3W
A BDS HYPERSIL C-18 column (150 mm × 4.6 mm, 5 µm particle 
size) equipped with PDA/UV detector with 280 nm as the detecting 
wavelength was used for chromatographic separations in room 
temperature (27°C) under the following conditions: 1 ml/min; 
solvent A, 10% acetic acid in water; solvent B, and 15% methanol in 
water starting from 0 to 20 min (40–52% A), 20 to 40 min (52–80% A), 
and 40 to 60 min (80% A).
The Synapt G2 HDMS ESI/APCI-Hybrid Quadrupole, Time-of-flight 
tandem mass spectrometer (Waters, USA) was used to identify S3W. The 
heated capillary and spray voltage were maintained at a temperature of 
275°C and 4.5kV. Nitrogen is operated at 40 psi for sheath gas flow rate 
and 26 psi for auxiliary/sheath gas flow rate. The full scan MS from m/z 
50–2000 were acquired in positive and negative ion mode with a scan 
speed of 1 s per scan. The MS was performed using argon as collision 
gas, operated at 0.1 mtorr.
NMR spectroscopy
Proton and carbon NMR spectra were obtained using Agilent 400MR 
DD2 NMR spectrometer at 400 MHz. Sample dissolved in 700 µl of 
dimethyl sulfoxide (DMSO)-d6 with concentration of 30 and 15 mg/ml 
for 13C and 1H, respectively, was prepared and transferred to a 5 mm NMR 
tube, wherein the analysis was performed at 45°C. The compound was 
identified by comparing spectra with that reported in literature [24,25].
Bacterial strains and cultivation
H. pylori were isolated and confirmed as per the protocol of Belagihalli 
and Dharmesh [5].
Inhibition of H. pylori viable colony count method
Bactericidal activity of the star fruit compound was determined 
using 96-well microtiter plate method [2]. 100 µl suspension of 
108 colony-forming units/ml was treated with 100 µl of distilled 
water (control) and S3W in concentration range of 2–10 µg/ml and 
absorbance read at 620 nm using an automatic ELISA microplate 
reader (Thermo Fisher, USA). The control consisted of H. pylori treated 
with sterile distilled water. The suspensions were incubated for 
3 days at 37°C under microaerophilic atmosphere and the absorbance 
read again in the same wavelength after agitation. All experiments 
were performed 3 times. The absorbance obtained before and after 
incubation was compared, and percentage inhibition using the 
following formula was used.
Percentage inhibition= 1 - 
OD of test
OD of control
The effectiveness of S3W at killing H. pylori was expressed as percentage 
inhibition of bacterial growth (i.e., percentage of bacteria killed) 
compared to that of control.
DNA protection assay
DNA protection assay was conducted by the inhibition of Fenton’s 
reagent induced strand breaks in lambda phage DNA by S3W [26]. The 
control group contained 5 µl of phage DNA and 5 µl Fenton’s reagent 
(30 mM H2O2, 500 µM ascorbic acid, and 800 µM ferric chloride) made 
up to 25 µl with distilled water, while the test group contained 5 µl 
phage DNA and 5 µl Fenton’s reagent followed by addition of 10 µl of 
1 mg/ml of S3W. The final volume was made up to 25 µl with distilled 
water, and the reaction mixtures were incubated for 45 min at 37°C. The 
strand break inhibition observed of test group was compared to that of 
control group using 0.9 % agarose gel electrophoresis by staining with 
ethidium bromide.
Buccal cell collection technique
A clean toothpick full of cheek buccal cells from healthy consenting 
donors was agitated in 2 ml cold phosphate buffer saline (PBS) 
(100 mM, pH 7) and centrifuged at 2500 rpm at 4°C for 10 min. The 
supernatant was aspirated and the cell pellet resuspended in 100 µl PBS.
Effect of S3W on buccal cells exposed to oxidant (ascorbic acid and 
FeSO4) and N- methyl N-nitrosourea (MNU)
To determine the effect of exposure of buccal cells to S3W in vitro, 
buccal cells were tested immediately after collection [27]. Buccal cells 
(1 × 104 cells/well) were exposed to 500 µM ascorbic acid and 500 µM 
FeSO4, and treated with and without 10 µg/ml S3W for 1 h at 37°C. 
Similarly, another set of buccal cells was treated with a carcinogen –
MNU (10 µg/ml for 1 × 104 cells/well) and exposed to the presence 
and absence of 10 and 20 µg/ml S3W for 1 h at 37°C. 1 µl of dye mix 
containing acridine orange and ethidium bromide of 100 µg/ml each 
was mixed to 25 µl cell suspension of treated and untreated cells. They 
were observed under the fluorescence microscope at ×40 (Olympus). 
Staining pattern between the cells was compared and cytoprotective 
ability of S3W was determined.
Animals
Experiments were performed using 6–8 weeks old Swiss albino 
mice, weighing 20–25 g. Animals were maintained in accordance 
with the OECD guidelines, and experiments were performed with 
the regulations of Farooqia College of Pharmacy, Mysuru, India (FCP/
EC- 5/273/2014- 2015).
Isolation of peritoneal macrophages and cell culture
Macrophages were isolated by peritoneal lavage from male Swiss 
albino mice [2]. The peritoneal cavity was washed with ice cold PBS 
supplemented with 20 U/ml heparin and 1 nM EDTA. Care was taken 
not to cause internal bleeding while collecting macrophages in the 
exudates. The cells were cultured in 60 mm Petri dishes in RPM1640 
media supplemented with 10% FBS, 50 µg/ml penstrap for 24 h at 37°C 
in a humidified atmosphere of 5% CO2 in CO2 incubator. Non-adherent 
cells were removed by vigorously washing 3 times with ice-cold PBS. 
Cell viability was evaluated by trypan blue exclusion and viable cells not 
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<95% was used for further studies. The Petri dishes containing the cells 
were divided into the following groups:
• Group I: Untreated cells (control)
• Group II: Cells treated with oxidant (ascorbic acid with FeSO4)
• Group III: Cells treated with MNU
• Group IV: Cells treated with oxidant + 20 µg/ml S3W
• Group V: Cells treated with MNU + 10 µg/ml S3W
• Group VI: Cells treated with MNU + 20 µg/ml S3W
The cells were stained with a mixture of acridine orange and ethidium 
bromide dye and morphologically analyzed under fluorescence 
microscope. The protocol described was in accordance to that reported 
by Mahapatra et al. with slight modifications [27].
Splenocyte proliferation assay
Effect of S3W on splenocyte proliferation was tested by MTT assay [28] 
wherein splenocyte suspension (1 × 106 cells/ml) in complete RPMI 
1640 medium was incubated in different concentrations of S3W 
(0–10 µg/ml) dissolved in 0.1% DMSO in PBS. Control splenocytes 
include those treated with 0.1% DMSO in PBS only. After incubation 
for 48 h at 37°C in 5% CO2 humidified atmosphere, the medium was 
removed and the adherent splenocytes were washed twice with 
PBS. 15 µL of MTT stock solution (5 mg/ml) was added to the culture 
medium for 4 h at 37°C. Absorbance was measured at 450 nm using 
microplate reader. Percentage splenocyte proliferation was calculated 





The assays were conducted in triplicates and data are represented as 
mean ± standard deviation. All statistical analysis was conducted using 
Origin 5.0.
RESULTS
Anti-H. pylori activity of S3W
Inhibitory potential of S3W against H. pylori growth analyzed by 
bacterial growth inhibition method is shown in Fig. 1. S3W expressed 
an IC50 value of 10.71 µg/ml.
DNA damage protection assay
DNA damage occurs through Fenton reaction generated by oxidants 
and carcinogens causing increase of its mobility in electrophoresis. 
Retardation of the S3W-treated DNA indicated that S3W recovered DNA 
from damage by the hydroxyl radicals (Fig. 2).
Protection of buccal cells from ascorbic acid/FeSO4 oxidant and 
MNU carcinogen damage
The cytoprotectivity on buccal cells treated with oxidant and MNU 
carcinogen is indicated in Fig. 3a-d. Intact viable cells stained green as 
they were bound more effectively by acridine orange than by ethidium 
bromide from the acridine orange/ ethidium bromide dye mixture 
whereas nuclear components of damaged cells stained more orange due 
to better interaction with ethidium bromide than to acridine orange. 
The oxidant and carcinogen induced clustering, cell disruption, and 
echnocytic type morphological alteration, whereas cells treated with S3W 
were normal indicating protection. Our results showed S3W-alleviated 
oxidative stress and protected the cells from undergoing cell damage.
Protection of peritoneal macrophages against oxidant 
(FeSO4+ascorbic acid) and MNU carcinogen damage
Macrophage cellular damage was caused by oxidation induced by ROS 
generated by FeSO4 and ascorbic acid and reactive nitrogen species 
(RNS) generated by MNU (Fig. 4b and d). Cellular damage was first 
evident by fragmented nucleus followed by degraded cytoplasm and 
membrane deregulation. These distinctive characters implicated 
that the oxidants induced apoptosis. Results show that treatment 
of macrophages with S3W protected the macrophages exposed to 
the oxidants and MNU from entering apoptosis (Fig. 4c, e, and f) by 
retaining the morphology of normal cell (Fig. 4a). Once again, S3W at 
20 µg/ml showed better macrophage protective effect against MNU 
carcinogen.
Fig. 1: Anti-Helicobacter pylori activity of S3W is expressed as 
percentage inhibition wherein its IC50 value is 10.7±0.192 µg/ml 
(n=4)
Fig. 2: Protection against DNA damage by S3W
Fig. 3: Fluorescent microscopic view of buccal cells protected 
N-nitroso-N-methylurea (MNU). (a) Control (b) buccal cells 
treated with MNU (c) buccal cells treated with 10 µg/ml S3W  
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Immunostimulatory activity as evaluated by proliferation of 
splenocytes by MTT assay
The star fruit oligosaccharide induced significant immunostimulatory 
activity indicated by a distinct splenocyte proliferation increase. The 
proliferation was dose dependent, wherein splenocyte proliferated by 
37 and 55.7% at 10 and 20 µg/ml concentration of S3W, respectively 
(Fig. 5). The resultant expression showed that S3W could be a potential 
mitogen.
Liquid chromatography–MS of star fruit oligosaccharide
The carbohydrate eluted at 2.574 min (Fig. 6a). The MS/MS spectra of 
isolated oligosaccharide generated by collision-induced dissociation 
(CID) were evaluated by assigning all product ions using the Domon-
Costello nomenclature [29]. Fig. 6b and c shows MS2 spectra of 
protonated and deprotonated oligosaccharides. The pattern of 
fragmentation indicated that the oligosaccharide was a low molecular 
weight sugar having O-2 linkages at the first and second residues with 
possible branching at C-4. Protonated oligosaccharides are prone to 
cleaving exclusively at glycosidic bonds [30]. However, due to prolonged 
exposure to higher voltage, the oligomer underwent cross-ring 
cleavage along with the expected glycosidic linkages. The protonated 
oligosaccharide displayed mass of m/z 1465. S3W (Fig. 6b) showed 
non-reducing B1 and B2 glycosidic cleavages at m/z 1303 and 978 
involving homolytic cleavage at (1→2) β- linkage bonds to release single 
glucose residue without the glycosidic oxygen at non-reducing terminal 
of backbone chain of m/z 162 and one (1→2) β-linked backbone glucose 
residue connected by a (4→6) α linkage. This accounted for mass loss 
of m/z 325. High-energy CID produced reducing fragmentation due to 
0,2A3 and 0,2A4 cleavage which generated fragment ions at m/z 853 and 
669, respectively. A unique feature of the MS was observation of a series 
of A-type cross-ring cleavages and C-type cleavage (Fig. 6b) bearing 
fragment ions of m/z 44 of varying relative intensities from m/z 405 to 
m/z 669. The formation of the fragment ions at m/z 44 was possibly due 
to the OH or –CH2OH group of the precursor ion being on the same ring 
carbons adjacent to the ring oxygen. Cross-link cleavages are frequently 
seen at reducing side of sugars [30]. Further, fragmentation led to 
the release of ions at m/z 388 and 361 due to the loss of –CHCH2OH 
releasing non- reducing terminal glucose of side chain and reducing 
terminal of glucose backbone of m/z 180 each.
Fig. 6c shows the deprotonated MS of the oligosaccharide. According to 
Domon and Costello nomenclature, a series of A and C type fragments 
ions are expected in MS at negative mode [31]. Hence, fragmentation 
could have started from the non-reducing end of the oligosaccharide. 
The spectrum contained 1,5A1 and C- type fragmentation to release m/z 
1331 and 1295 although the molecular ion peak of m/z 1475 was not 
detected. 1,5A1α, C2, and 1,5A4 fragmentation released fragment ions at 
m/z 1007, 971, and 683, respectively. The glucose backbone continued 
through a series of A- and C-type cleavage releasing ions of m/z 359, 
323, and 215 (Fig 6c). The fragmentation pattern in negative mode was 
a characteristic of a (1→2) β-linked saccharide with alternating (4→6) 
α-branching.
NMR spectroscopy of S3W
From information of coupling constant (Supplementary material 2) at 
8 Hz and 3.6 Hz, 4.231 ppm was assigned for β-D-glucose and 4.883 
to α-D-glucose. The resonances of one of the methylene protons of the 
branch point glycosyl repeat unit at 3.225 ppm were similar to that of 
integrated area of the anomeric proton suggesting a singly branched 
side chain of (4→6) α-linkages. The ratio of the areas from resonances 
assigned to H1 of side chain residue at and H1 of the (1→2) β-linked 
repeat units in the polymer indicated that the side chain attached to 
the backbone on average every two repeat units. Coupling constant of 
11.2 Hz at 4.161 ppm was assigned to 3JH2-H3. 92.630 ppm was assigned 
to α-C-1 of (4→6)- α side chain (SC) and 97.281 to β- C-1 of reducing 
terminal (RT) of (1→2)-β-glycosyl backbone. 104.591 ppm was assigned 
to β-C-1 of non- reducing terminal, while 102. 389 ppm was assigned 
to β- C-1 of internal residues. The presence of (1→2)-β-bonding was 
evident by the presence of resonance at 81.444 to 83.751 ppm for C-2 
at the reducing terminals, while resonance at 75.253 ppm was assigned 
to C-2 of non-reducing terminal. Single branching at (4→6)-α produced 
C-4 resonance at 77.096 to 77.156 ppm and C-6 resonance at 69.279–
69.302 ppm. Unsubstituted C-4 resonated at 70.334–71.010 ppm, while 
that by C-6 at 61.653–63.712 ppm. The rest of the proton and carbon 
NMR assignments are summarized in Table 1.
The resonance and MS analysis agreed with each other indicating the 
oligosaccharide likely to possess a (1→2) β-linked heptasaccharide 
backbone with alternating (4→6) α-linked glycosyl branches (Fig. 7).
DISCUSSION
Glycobiologists have stated the wide scope for the applications of 
novel carbohydrate-based drugs particularly that of oligosaccharides 
to modulate the immune system since native polysaccharides and 
glycoconjugates have their large size (MW 10–1000 kDa) as one of 
the limitations for their value in drug discovery. Oligosaccharide as a 
secondary metabolite from star fruit was isolated using adsorption 
methods and partially characterized for the first time. Separation of 
carbohydrates is extensively carried out using high-pressure liquid 
chromatography while MS is a widely used tool to study its structure [31]. 
ESI is one of the common methods for carbohydrate analysis. However, 
the hydrophilicity of carbohydrates decreases its ionization efficiency, 
Fig. 5: Percentage proliferation of splenocytes treated with S3W 
as an indicator of immunostimulatory effect of S3W (n=4)
Fig. 4: Fluorescent microscopic view of macrophages protected 
against oxidant and N-nitroso-N-methylurea (MNU) (a) Control 
(b) macrophages treated with oxidant (FeSO4+ascorbic acid) 
(c) macrophages treated with 20 µg/ml S3W (d) macrophages 
treated with MNU carcinogen (e) macrophages treated with 
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particularly in increasing molecular weight [32]. Hence, an APCI/
ESI hybrid was used to improve the efficiency of the ionization of the 
oligosaccharide. Substantial use of MS for determining carbohydrate 
structure using the nomenclature of Domon and Costello has been 
recorded [33-37], wherein CID on carbohydrates produces distinct CID 
fragmentation explaining the linkage type and anomeric configuration. 
This, along with ESI to ionize oligosaccharides connected to tandem MS 
(MS/MS), is useful tool to elucidate carbohydrate structure. Protonated 
oligosaccharide cleavage generally occurs at the non-reducing side of 
the glycosidic oxygen (B- and Z-type). In negative mode, fragmentation 
patterns with C-and A-type ions are more common [25] compared to 
B-type fragments. The cross-link cleavages exposed the type of linkage 
present in the oligo/polysaccharides. The isolated oligosaccharide in 
negative mode fragmented into distinctive ions of mass m/z 108, 215, 
and 195 which characterized the underivatized oligosaccharide as to 
possess a β (1→2) glycosidic linkage despite formation of abundant 
internal fragments. NMR is the most efficient technique to structurally 
analyze glycans [32]. It provides most of the experimental data to 
determine glycosidic linkages of carbohydrates from natural sources. 
In 1H NMR spectroscopy, the anomeric protons are generally located 
at 4.2–5.8 ppm, while ring protons are found in the 3.2–4.5 ppm 
region. The large 13C chemical shift differences due to conformational 
and configurational changes made 13C NMR spectroscopy a useful 
instrument to elucidate structures of star fruit oligosaccharides. 
Carbons involved in glycosylation exhibit a large downfield shift of 
approximately 4–10 ppm [38]. Slight upfield shifts at C3, C4, and 
C5 of 0.5~2 ppm due to the β-effect of 1→2 linkage were evident. 
Downfield shifts of 7–8 ppm indicated the β (4→6) linkage of the side 
chain. Based on comparison with resonances reported for β (1→2) 
glucans, distinctive shifts for 13 C and 1H were assigned [24]. The results 
were in agreement with that reported. Characteristic resonance for 
anomeric carbon and hydrogen revealed the oligosaccharide to be a β 
(1→2)-linked glycan with α (4→6) branching. It is, however, essential to 
employ 2D NMR analysis to completely elucidate the oligosaccharide.
Macrophages are critical components in immunity as they interact 
with T cells, B cells, natural killer cells, dendritic cells, neutrophils, and 
fibroblasts to phagocytize microorganisms in an attempt to kill them 
using ROS/RNS. Buccal cells, on the other hand, are the first barriers 
during inhalation or ingestion route, capable of metabolizing proximate 
carcinogens to reactive products, thus representing a preferred 










(4→6)‑ α‑ Br SC1
H1 4.251 4.251 4.231 4.251 4.883
H2 3.509 3.249 3.257 3.089 3.662
H3 3.613 3.418 3.407 3.706 3.113
H4 3.348 3.348 3.367 3.798 3.089
H5 3.638 3. 377 3.367 3.798 3.349
H6 3.787 3.798 3.787 4.131 4.133
H6’ 3.662 3.613 3.638 3.613 3.688
C1 102.389 104. 597 97.281 101.569 92.630
C2 83. 751 75.253 82. 294 71.010 72.762
C3 77.096 77.096 77.096 83.751 73.521
C4 70.334 71.010 71.010 77.156 71.010
C5 77.156 78.416 77.156 75.775 75.258
C6 63.299 61.653  64.817 69.848 63.482
Fig. 6: High‑performance liquid chromatography (HPLC)-electrospray ionization-mass spectrometry of S3W (a) HPLC chromatogram of 
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target site for early genotoxic events induced by carcinogens [39,40]. 
Eradication of H. pylori is strongly recommended to overcome gastric 
diseases such as gastric cancers as it plays the predominant role of being 
the main etiological agent for these gastric disorders. H. pylori hampers 
immunostimulation for its survival and causes the overproduction 
of ROS and RNS which itself harms host cells such as marcophages, 
neutrophils, and splenocytes [2]. Studies have suggested that such self-
harm could be mainly due to ROS being able to eliminate any bacteria 
within the vicinity of the phagocyte, but separation between the 
phagocytes and the bacteria in the lumen curbs efficient elimination of 
H. pylori [3]. As a result, excess production of ROS and RNS damages DNA 
beyond its repair capabilities. This prolonged combined damage can 
also initiate the process of carcinogenesis. The therapeutic compounds 
are thus required to bear properties that enhance immunostimulatory 
effects and prevent progressive tumorogenesis. Kojima et al. observed 
that carbohydrate carriers reduced the affinity of H. pylori adhesion to 
antigens on gastric mucosa [41] which might explain the limitations of 
using carbohydrates as anti-H. pylori agents. The in vitro studies of the 
effect of star fruit glycan, however, showed promising potential. S3W 
was highly potent against H. pylori proliferation and its mechanism can 
be attributed to its anti-radical and immunostimulatory properties. 
Macrophages exposed to oxidants and MNU, a carcinogen most notably 
to cause adenocarcinoma of the stomach [42], were protected by S3W 
from undergoing damage significantly. Enhancement of phagocyte 
function is an established therapeutic application against microbial 
infection and cancer. Carbohydrates isolated from various medicinal 
plants possessed ability to regulate macrophage function resulting 
from its immune-stimulating activity [43,44]. β-glucans are postulated 
to act as pathogen-associated molecular pattern (PAMP) which 
binds to typical macrophages and dendritic cell surface receptors 
called pattern recognition receptors (PRRs) that detect innately 
non-self-molecules such as PAMPs. On binding, the PRRs can induce 
cascade of signals activating immune cells [45]. Thus, the ability of 
S3W to behave as a PAMP can be analyzed in future studies. Spleen 
as a blood filter responds to systemic infection by trapping blood 
born antigens wherein splenocytes in coordination with B and T 
lymphocytes help in pathogen clearance in the body primarily through 
antibody formation and secretion. An increase in the concentration 
of splenocytes enhances acquired immunity and is an important 
criterion of immunostimulation [26]. Elaborate records of the effect 
of oligosaccharides such as nigerose oligosaccharides, asparagine-like 
oligosaccharides, synthetic β (1→6) branched β (1→3) gluco-hexose, 
fructooligosaccharides, chitosan oligosaccharides, and many more in 
augmentation of splenocyte proliferation resulting in its production 
of many cytokines such as interleukin-2 (IL-2), interferon-γ, IL-6, and 
tumor necrosis factor α are available [35,46-49]. There, however, are no 
substantial reports of immunomodulatory effect of (1→2) α/β linked 
oligosaccharides. The present study is the first to reveal a star fruit 
oligosaccharide which is most probably (1→2)- β- linked, expressing for 
the first time the significant mitogenic property evident by the enhanced 
splenocytes proliferation by more than 50% at 20µg/ml compared to 
untreated splenocytes. To our knowledge, such significant reports of 
star fruit oligosaccharides have not been published elsewhere. It is 
evident that the use of oligosaccharides from natural sources for its 
anti-H. pylori potential, particularly, is in its infancy. There is a wide 
scope to extensively study and further establish oligosaccharides in drug 
discovery. Our investigation is the first to highlight the distinct potential 
of (1→2)- β, (4→6) – α linked oligosaccharide isolated from fruit of star 
fruit as an agent against gastric cancer caused by H. pylori through 
its immunomodulatory functions. Future studies are encouraged to 
analyze immune factors released as a result of immunomodulation by 
the star fruit oligosaccharide and establish the molecular mechanism.
CONCLUSION
Star fruit oligosaccharide showed anti-H. pylori activity through 
immunomodulatory effects by protecting DNA from damage caused by 
free radicals, cytoprotection from carcinogen like MNU, and stimulating 
proliferation of splenocytes. The oligosaccharide has a therapeutic 
potential for application in immunotherapy. Further research to 
understand the molecular mechanism by which the oligosaccharide 
can protect and induce proliferation of immune cells to promote 
anti H. pylori activity is encouraged.
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